Amyloid drugs for Alzheimer’s debate heats up
The battle over how we treat Alzheimer’s disease has reached a fever pitch. On one side, we have the gold-standard rigor of the Cochrane review, suggesting that clearing amyloid plaques from the brain is like painting a house while the foundation is crumbling—it looks better on a scan, but the structure is still failing. On … Read more